Attachment
Gates Package, p.902 · gates:exh:00312
Page text: p.902 · original PDF
- Date
- — (unknown precision)
- Type
- attachment · document
A potentially threatening disease is rapidly detected by local public health
agencies, which function effectively in even the world's poorest countries.
Anything out of the ordinary is shared with capable labs for study, including
genetic sequencing, and the information uploaded to a global database that is
being monitored by a dedicated team.
When a threat is detected, governments sound the alarm and initiate public
recommendations for travel, social distancing, and emergency planning.
We start using the blunt tools that we already have on hand, such as mandatory
quarantines, antivirals that protect against almost any strain, and tests that can
be performed in any health clinic, workplace, or home.
If that isn't sufficient, then the world's innovators immediately get to work
developing tests, treatments, and vaccines for the pathogen. Diagnostics in
particular ramp up extremely fast so that large numbers of people can be tested
in a short time.
New drugs and vaccines are approved quickly, because we've agreed ahead of
time on how to run trials quickly and share the results. Once they're ready to
go into production, manufacturing gears up right away because factories are
already set up and approved.
No one gets left behind, because we've already worked out how the new tools
will be allocated and how to rapidly make enough for everyone.
Everything gets where it's supposed to, when it's supposed to, because we've set
up systems to get products delivered all the way to the patient.
Communications about the situation are clear and avoid pani.c.